(Q63317163)
Statements
Efficacy and Safety of Induction Therapy With Three Doses of Infliximab in Patients With Crohn Disease Aged 7-17 Years-multicenter Open Study. Efficacy and Safety of Two Regimens of Maintenance Therapy in Patients With Crohn Disease Aged 7-17 Years-multicenter Randomized Study (English)
0 references
November 2008
0 references
April 2012
0 references
100
0 references
7 year
0 references
17 year
0 references